-
Track & Monitor
Innovation in pharma: antibody encoding polynucleotide libraries
Our team of industry experts has meticulously researched and analyzed the latest trends, innovations and emerging technologies in the pharma industry’s antibody encoding polynucleotide libraries segment. By leveraging our report, you will gain invaluable insights that can revolutionise your business strategies and give you a competitive edge. Note: This is an “on-demand” report and will be delivered within 2 to 4 business days (excluding weekends and holidays) of the purchase. Certain sections in the report may be removed or altered...
-
Company Profile
NewCullinan Oncology Inc – Company Profile
Cullinan Oncology Inc (Cullinan Oncology) clinical-stage biotechnology company. It focuses on the discovery and development of oncology therapies. Its product pipeline includes CLN-081 for the treatment of non-small cell lung cancer; CLN-619 against pan-cancer; and CLN-049 to treat relapsed and refractory acute myelogenous leukemia (AML), and myelodysplastic syndrome (MDS). Cullinan Oncology’s pipeline also includes drug programs such as CLN-418 for multiple solid tumors; CLN-978 to treat B-cell non-Hodgkin lymphomas; and CLN-617 for treatment of pan-cancer. The company also provides various...
Add to Basket -
Track & Monitor
Artificial Intelligence in Pharmaceuticals: In-silico drug discovery
Our team of industry experts has meticulously researched and analyzed the latest trends, innovations and emerging technologies in the Pharmaceuticals industry’s In-silico drug discovery segment. By leveraging our report, you will gain invaluable insights that can revolutionise your business strategies and give you a competitive edge. Note: This is an “on-demand” report and will be delivered within 2 to 4 business days (excluding weekends and holidays) of the purchase. Certain sections in the report may be removed or altered based...